Immunotherapy plus stereotactic radio-surgery: building on the promise of precision medicine for CNS malignancies

There is increasing evidence that the brain is not completely shielded from the systemic immune system, and this has renewed interest in the use of immunotherapy agents in conjunction with radiotherapy to create an additive, and perhaps synergistic, immune response.
Cancer Network